iTRAQ-Based Proteomic Analysis of Ginsenoside F₂ on Human Gastric Carcinoma Cells SGC7901

Figure 6

Western blot validations of RPS15, RPL26, PRR5, CISD2, NLRX1, p53, PUMA, mTOR, and Bcl-xl in SGC7901 cells with different concentrations of ginsenoside F₂. 1 × 10⁶ SGC7901 cells are seeded in 6-well plate for overnight. On day 2, the cultured cells are treated with different concentration ginsenoside F₂. 12 hours after treatment, the protein is prepared by lysating cells with RIPA buffer for performing western blot analysis. Left panel: the representative western blot analysis. β-actin was used as the loading control. Right panel: accumulated results show the relative protein density. Error bars represent means ± SEMs. Significant difference is expressed as , .

(a)

(b)